TI
AXSM icon

Trexquant Investment’s Axsome Therapeutics AXSM Stock Holding History

Trexquant Investment’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Sell
5,935
-43,201
-88% -$7.46M 0.01% 1230
2025
Q4 		$8.97M Buy
49,136
+39,615
+416% +$5.53M 0.08% 352
2025
Q3 		$1.16M Buy
+9,521
New +$1.07M 0.01% 1096
2025
Q1 		– Sell
-14,129
Closed -$1.2M – 1546
2024
Q4 		$1.2M Buy
+14,129
New +$1.3M 0.01% 1042
2023
Q4 		– Sell
-17,450
Closed -$1.22M – 1421
2023
Q3 		$1.22M Buy
+17,450
New +$1.3M 0.03% 672
2023
Q2 		– Sell
-22,732
Closed -$1.4M – 1436
2023
Q1 		$1.4M Sell
22,732
-1,223
-5% -$80.3K 0.04% 590
2022
Q4 		$1.85M Buy
+23,955
New +$1.43M 0.05% 430
2022
Q1 		– Sell
-8,508
Closed -$321K – 1348
2021
Q4 		$321K Buy
8,508
+1,993
+31% +$73.3K 0.02% 879
2021
Q3 		$215K Buy
+6,515
New +$254K 0.02% 922
2020
Q3 		– Sell
-10,102
Closed -$831K – 1188
2020
Q2 		$831K Sell
10,102
-19,018
-65% -$1.46M 0.06% 459
2020
Q1 		$1.71M Buy
29,120
+26,809
+1,160% +$2.18M 0.12% 252
2019
Q4 		$239K Sell
2,311
-14,758
-86% -$596K 0.01% 840
2019
Q3 		$345K Buy
+17,069
New +$439K 0.03% 578
2018
Q1 		– Sell
-22,911
Closed -$128K – 1065
2017
Q4 		$128K Buy
+22,911
New +$116K 0.01% 992

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's AXSM Position: Q1 2026 in Review

Trexquant Investment reduced its Axsome Therapeutics (AXSM) stake by 88% in Q1 2026, selling an estimated $7.46M and leaving 5,935 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #1230.

Trexquant Investment first reported a position in AXSM in Q4 2017 and has held it in 14 quarters since. The position peaked at $8.97M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Trexquant Investment held 5,935 shares of Axsome Therapeutics worth $1M as of Q1 2026.
  • Trexquant Investment sold 43,201 Axsome Therapeutics shares in Q1 2026, an estimated $7.46M.
  • Axsome Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1230 holding.
  • Trexquant Investment first reported a position in Axsome Therapeutics in Q4 2017 and has held it in 14 quarters since.
  • Trexquant Investment's Axsome Therapeutics position peaked at $8.97M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.